RE: Bravo Vlad27 Nov 2025 13:10
Alde - it's a failsafe that we're hoping they don't have to use, sure or at least not in the manner where it's an emergency rip-cord being pulled. They're in discussions with pharma currently as stated, so we don't know exactly where things are. It probably wouldn't be our ideal position, no....failsafe's tend not to be...but it's certainly not the worst position that is articulated and NP keeps pushing the worst for their own motives. NP and you also push hard that £5.6m is needed by January or everything falls over. £5.6m is needed for all of 2026. I think the wording in the prospectus around that is clumsy, but it is clear enough if read properly. I'm not sure if it's a going concern requirement or another equity raise rules requirement that is making them quote things the way they are, but I'm fine with what it means and that includes cover for corp costs and a little on other R&D.
As for NP attacking the funding and JHFH continually - everyone on this site has their personality quirks, but continually attacking JHFH and trying to undermine the hard work Haywain and he did that started this SP rise is ridiculous. I'm not saying all LTH's motives are pure (I am aware of how that equity raise went and I know at least one revealed true colours), but the vast majority are pushing hard and willing hard for this to be a success and to help the company. Do I doubt that we will find the money we need in some form for January...no. Might it hurt more than I'd want...maybe. Are we in the decent position we are because of help from JHFH / Haywain...absolutely. Where do you think your TR1 (and likely other TR1's) come from?